Dr. Yan-Gao Man received his medical and MS degrees from the Hubei Medical College of China, and PhD in Cell Biology/Anatomy in 1998 from Howard University Medical School, Washington DC. He completed postdoctoral training in Cancer Biology in 1999 at the National Cancer Institute, NIH, Bethesda, MD, USA. He served as the Director of the Gynecological and Breast Research Laboratory, Armed Forces Institute of Pathology and American Registry of Pathology, from 1995 to 2011, and as a Senior Scientist and Senior Distinguished Scientist at the Diagnostic and Translational Research Center, Henry Jackson Foundation, from 2011 to 2013. Currently, he serves as Co-Director, Laboratory of Proteomics and Protein Sciences, Veterans Affair Health System, Baltimore, MD, an Adjunct Senior Scientist, at Hackensack University Medical Center, Hackensack, NJ, USA, and as a Vice President for Research and Collaboration, at the South Hospital of Nanjing, Nanjing, China. He is also a Visiting Professor of the Jilin University, China, an Associate Editor-In-Chief of Cancer Epidemiology, an Editorial Board Member of The Open Breast Cancer Journal, and a grant review panel member for a number of international and national cancer-research organizations.
Dr. Man has authored and co-authored over 180 published scientific papers and abstracts, 46 non-scientific articles, 4 book chapters, and 14 novel protocols for molecular and immunohistochemical assays. He was the recipient and co-recipient of 18 funded research grants and inventor and co-inventor of 3 patents. Currently, Dr. Man’s research interests focus primarily on the mechanism of tumor invasion and metastasis. He is the originator of novel hypotheses for both tumor invasion and metastasis. His hypotheses have increasingly gained recognition, and he has been invited by colleagues in the National Institutes of Health, Dana-Farber Cancer Institute of Harvard Medical School, Johns Hopkins University, UCLA, Barbara Ann Karmanos Cancer Institute, Florida State University, and a number of other international prestigious Institutions to present his hypotheses. His hypothesis of tumor invasion has been recognized as more compatible with existing experimental evidence than the traditional “protoelytic enzyme” theory [Pandey PR et al. Front Biosci. 15: 226–236, 2011].
Updated on June 10, 2016
Dr. Naoto T. Ueno gained his medical degree in 1989 from Wakayama Medical College, Wakayama, Japan, and PhD in Cancer Biology from The University of Texas Graduate School of Biomedical Sciences, Houston, TX, in 1999. He is currently full professor and Chief of the Translational Breast Cancer Research Section of Department of Breast Medical Oncology, and Executive Director of the Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center. He also serves as the Committee Chair of Solid Tumor Committee of Center for International Blood & Marrow Transplant Research (CIBMTR), Milwaukee, WI. Dr. Ueno is on Board of Directors for Japan Comprehensive Cancer Network, Breast (Tokyo, Japan), Chair of Sister Institution between Tokyo Oncology Consortium and MD Anderson Cancer Center, and Chair of MD Anderson Cancer Center Breast Cancer Bone Metastasis Working Group. Dr. Ueno was Chair of The European Group for Blood & Marrow Transplantation, 2nd International Meeting of Allogeneic Transplantation for Solid Tumor, Milan, Italy, 2005, and Chair of The European Group for Blood & Marrow Transplantation, 3rd International Meeting of Allogeneic Transplantation for Solid Tumor, Siena, Italy, 2008. Dr. Ueno's primary research interest is dissecting the molecular events related to cytotoxicity induced by chemotherapy or targeted therapy for breast cancer and ovarian cancer. His research is well funded by NIH and Susan G. Komen Breast Cancer Foundation. Dr. Ueno is author or co-author of more than 120 articles in peer-reviewed journals, 17 book chapters, and 46 abstracts.
Updated on March 5, 2013